BackValeo Pharma Overview
Valeo Pharma Inc.

Valeo Pharma Return on Equity

Valuation check: VPHIF's ROE is 50.96%, above the sector sector average of 11.3%.

Get informed when a big investor buys or sells

+ Follow

ROE

50.96%

Return on Equity

50.96%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Valeo Pharma (VPHIF) FAQ

As of the most recent data, VPHIF shows a ROE of 50.96%. That is above the sector sector average of 11.3%. Scroll down for historical charts and peer comparison views.

The its sector sector average ROE is about 11.3%. Valeo Pharma is at 50.96%, which is higher that average. That is roughly 351.1% above the sector mean. Use the comparison chart on this page to see how VPHIF stacks up against individual peers as well.

Check the historical chart to see whether VPHIF's ROE is trending up or down. Improvement over multiple periods is generally more meaningful than a single strong quarter. Compare Valeo Pharma with peers to see if the move is company-specific or sector-wide.

Besides this return on equity page, Stockcircle has Valeo Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect ROE (currently 50.96%) with ownership activity and broader fundamentals.